Isley WL - Search Results

1

Patient-important outcomes in registered diabetes trials.

Gandhi GY, Murad MH, Fujiyoshi A, Mullan RJ, Flynn DN, Elamin MB, Swiglo BA, Isley WL, Guyatt GH, Montori VM. Gandhi GY, et al. Among authors: isley wl. JAMA. 2008 Jun 4;299(21):2543-9. doi: 10.1001/jama.299.21.2543. JAMA. 2008. PMID: 18523223

2

Waking up from the DREAM of preventing diabetes with drugs.

Montori VM, Isley WL, Guyatt GH. Montori VM, et al. Among authors: isley wl. BMJ. 2007 Apr 28;334(7599):882-4. doi: 10.1136/bmj.39169.447488.94. BMJ. 2007. PMID: 17463460 Free PMC article. Review.

3

Ramipril did not reduce incident diabetes in patients with impaired glycemic control.

Gandhi GY, Isley WL. Gandhi GY, et al. Among authors: isley wl. ACP J Club. 2007 Jan-Feb;146(1):10. ACP J Club. 2007. PMID: 17203930 No abstract available.

4

Review: ACE inhibitors and angiotensin-receptor blockers reduce diabetes in hypertension and other CV risk factors.

Gandhi GY, Isley WL. Gandhi GY, et al. Among authors: isley wl. ACP J Club. 2007 Jan-Feb;146(1):11. ACP J Club. 2007. PMID: 17203931 No abstract available.

5

Problems with measurements of hemoglobin A1c.

Smith SA, Montori VM, Isley WL, Burritt MF. Smith SA, et al. Among authors: isley wl. Mayo Clin Proc. 2006 Aug;81(8):1130. doi: 10.4065/81.8.1130. Mayo Clin Proc. 2006. PMID: 16901036 No abstract available.

6

Glycemic variation and hypoglycemia in patients with well-controlled type 1 diabetes on a multiple daily insulin injection program with use of glargine and ultralente as basal insulin.

Kudva YC, Basu A, Jenkins GD, Pons GM, Vogelsang DA, Rizza RA, Smith SA, Isley WL. Kudva YC, et al. Among authors: isley wl. Endocr Pract. 2007 May-Jun;13(3):244-50. doi: 10.4158/EP.13.3.244. Endocr Pract. 2007. PMID: 17599855 Clinical Trial.

7

Prevalence of diabetic peripheral neuropathy and relation to glycemic control therapies at baseline in the BARI 2D cohort.

Pop-Busui R, Lu J, Lopes N, Jones TL; BARI 2D Investigators. Pop-Busui R, et al. J Peripher Nerv Syst. 2009 Mar;14(1):1-13. doi: 10.1111/j.1529-8027.2009.00200.x. J Peripher Nerv Syst. 2009. PMID: 19335534 Free PMC article.

8

Review: alpha-glucosidase inhibitors improve glycemic control but have uncertain effects on patient-important outcomes in type 2 diabetes.

Isley WL. Isley WL. ACP J Club. 2005 Nov-Dec;143(3):66. ACP J Club. 2005. PMID: 16262223 No abstract available.

9

Randomized controlled clinical trial of glargine versus ultralente insulin in the treatment of type 1 diabetes.

Kudva YC, Basu A, Jenkins GD, Pons GM, Quandt LL, Gebel JA, Vogelsang DA, Smith SA, Rizza RA, Isley WL. Kudva YC, et al. Among authors: isley wl. Diabetes Care. 2005 Jan;28(1):10-4. doi: 10.2337/diacare.28.1.10. Diabetes Care. 2005. PMID: 15616226 Clinical Trial.

10

The effect of high-dose simvastatin on free fatty acid metabolism in patients with type 2 diabetes mellitus.

Isley WL, Harris WS, Miles JM. Isley WL, et al. Metabolism. 2006 Jun;55(6):758-62. doi: 10.1016/j.metabol.2006.01.013. Metabolism. 2006. PMID: 16713435 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

73 results

Search Page